Precision medicine represents both a business and clinical opportunity for multiple healthcare stakeholders. At times of significant healthcare challenges, it is a clear means of combining emerging technologies with in-depth disease understanding to deliver better care to patients. Pharmaceutical companies can seize this opportunity — or ignore it and watch their competitors pass them by.
0 Comments